$RNVA
Rennova Health, Inc. Stock $rnva

$rnva Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017256 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$6.400M	$4.900M	$5.459M
YoY Change	77.78%	328.13%	182.07%
Cost Of Revenue	$1.834M	$1.853M	$1.998M
YoY Change	16.7%	34.8%	64.01%
Gross Profit	$4.566M	$3.047M	$3.461M
YoY Change	125.11%	-1424.07%	382.61%
Gross Profit Margin	71.34%	62.18%	63.4%
Selling, General & Admin	$2.359M	$2.217M	$1.946M
YoY Change	25.45%	40.98%	228.64%
% of Gross Profit	51.66%	72.75%	56.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$99.36K	$94.14K	$117.9K
YoY Change	-15.24%	-19.42%	-9.05%
% of Gross Profit	2.18%	3.09%	3.41%
Operating Expenses	$2.458M	$2.311M	$2.064M
YoY Change	23.07%	36.8%	185.95%
Operating Profit	$2.097M	$752.0K	$1.397M
YoY Change	5540.12%	-139.18%	-30610.48%
Interest Expense	-$431.5K	-$552.3K	-$552.0K
YoY Change	-9.97%	-11.06%	-19.13%
% of Operating Profit	-20.58%	-73.43%	-39.51%
Other Income/Expense, Net	-$295.4K	$53.52K	$412.5K
YoY Change	-44.99%	-306.54%	-66.63%
Pretax Income	$1.802M	$805.6K	$1.144M
YoY Change	-460.43%	-135.55%	-258.69%
Income Tax	$517.0K		$312.9K
% Of Pretax Income	28.7%		27.34%
Net Earnings	$1.278M	$800.0K	$819.9K
YoY Change	-353.65%	-135.28%	-190.78%
Net Earnings / Revenue	19.97%	16.33%	15.02%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	29.93B shares	29.93B shares	29.08B shares
Diluted Shares Outstanding	482.1B shares	509.8B shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$725.5K	$251.2K	$499.5K
YoY Change	471.82%	143.24%	-31.06%
Cash & Equivalents	$725.5K	$251.2K	$499.5K
Short-Term Investments
Other Short-Term Assets	$383.5K	$320.4K	$215.4K
YoY Change	281.32%	221.49%	76.71%
Inventory	$235.4K	$277.2K	$242.6K
Prepaid Expenses
Receivables	$2.881M	$2.849M	$3.111M
Other Receivables	$2.334M	$1.771M	$1.457M
Total Short-Term Assets	$7.397M	$6.306M	$6.363M
YoY Change	59.96%	48.97%	34.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.278M	$4.321M	$4.194M
YoY Change	-3.42%	-18.59%	-9.41%
Goodwill
YoY Change
Intangibles	$259.4K	$259.4K	$259.4K
YoY Change	0.0%		0.0%
Long-Term Investments	$9.016M	$9.016M	$9.016M
YoY Change	0.0%	0.0%	0.0%
Other Assets	$164.4K	$164.4K	$165.5K
YoY Change	-16.88%	-16.88%	-11.86%
Total Long-Term Assets	$14.16M	$14.27M	$14.21M
YoY Change	-3.07%	-3.48%	-4.73%
TOTAL ASSETS
Total Short-Term Assets	$7.397M	$6.306M	$6.363M
Total Long-Term Assets	$14.16M	$14.27M	$14.21M
Total Assets	$21.56M	$20.57M	$20.57M
YoY Change	12.09%	8.2%	4.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.01M	$11.76M	$11.51M
YoY Change	7.36%	-8.65%	-5.12%
Accrued Expenses	$19.32M	$20.01M	$19.56M
YoY Change	11.82%	23.49%	26.22%
Deferred Revenue
YoY Change
Short-Term Debt	$8.222M	$8.322M	$8.622M
YoY Change
Long-Term Debt Due	$11.79M	$13.11M	$14.53M
YoY Change	-17.21%	-10.97%	-3.21%
Total Short-Term Liabilities	$48.30M	$48.55M	$49.31M
YoY Change	2.01%	3.21%	6.35%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$271.6K	$316.1K	$359.2K
YoY Change	-40.5%	-42.2%	-37.45%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.30M	$48.55M	$49.31M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$48.57M	$48.86M	$49.67M
YoY Change	1.6%	2.69%	5.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.701B	-$1.703B	-$1.704B
YoY Change	-0.09%		24.4%
Common Stock	$2.993M	$2.993M	$2.908M
YoY Change	608.45%		685850.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$27.00M	-$28.30M	-$29.10M
YoY Change
Total Liabilities & Shareholders Equity	$21.56M	$20.57M	$20.57M
YoY Change	12.09%	8.2%	4.78%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$1.278M	$800.0K	$819.9K
YoY Change	-353.65%	-135.28%	-190.78%
Depreciation, Depletion And Amortization	$99.36K	$94.14K	$117.9K
YoY Change	-15.24%	-19.42%	-9.05%
Cash From Operating Activities	$2.206M	$1.141M	$948.3K
YoY Change	-3871.67%	-199.09%	-129.42%
INVESTING ACTIVITIES
Capital Expenditures	$56.53K	$220.5K	$440.00
YoY Change	-266.56%
Acquisitions
YoY Change
Other Investing Activities	-$563.2K	-$313.9K	-$363.4K
YoY Change	31.29%
Cash From Investing Activities	-$619.7K	-$534.3K	-$363.9K
YoY Change	33.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.112M	-$855.2K	-95.87K
YoY Change	-304.0%	-261.22%	-102.65%
NET CHANGE
Cash From Operating Activities	2.206M	$1.141M	948.3K
Cash From Investing Activities	-619.7K	-$534.3K	-363.9K
Cash From Financing Activities	-1.112M	-$855.2K	-95.87K
Net Change In Cash	474.3K	-$248.2K	488.5K
YoY Change	1910.6%		24.3%
FREE CASH FLOW
Cash From Operating Activities	$2.206M	$1.141M	$948.3K
Capital Expenditures	$56.53K	$220.5K	$440.00
Free Cash Flow	$2.149M	$920.8K	$947.8K
YoY Change	-8857.7%	-179.95%	-129.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000931059
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax		usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	RNVA	Stock Issued During Period Value Conversion Of Series O Preferred Stock Into Common Stock StockIssuedDuringPeriodValueConversionOfSeriesOPreferredStockIntoCommonStock		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	RNVA	Income Loss From Discontinued Operation Net Of Tax IncomeLossFromDiscontinuedOperationNetOfTax		usd
CY2023Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2022Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2023Q1	RNVA	Payments Of Accounts Receivable Sold Under Sales Agreements PaymentsOfAccountsReceivableSoldUnderSalesAgreements		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023Q1	RNVA	Cash Paid For Fractional Shares In Connection With Reverse Stock Split CashPaidForFractionalSharesInConnectionWithReverseStockSplit		usd
CY2023Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2022Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock		shares
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q1	RNVA	Property Plant And Equipment And Finance Lease Right Of Use Asset PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAsset		usd
CY2022Q4	RNVA	Property Plant And Equipment And Finance Lease Right Of Use Asset PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAsset		usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2023Q1	RNVA	Finance Lease Payments FinanceLeasePayments		usd
CY2022Q1	RNVA	Finance Lease Payments FinanceLeasePayments		usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	RNVA	Conversion Of Preferred Stock Into Common Stock Two ConversionOfPreferredStockIntoCommonStockTwo		usd
CY2023Q1	RNVA	Deemed Dividends From Exchanges Of Debt For Preferred Stock DeemedDividendsFromExchangesOfDebtForPreferredStock		usd
CY2023Q1	RNVA	Deemed Dividends For Trigger Of Down Round Provisions DeemedDividendsForTriggerOfDownRoundProvisions		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35141
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	RENNOVA HEALTH, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	68-0370244
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 S. Australian Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
CY2023Q1	dei	City Area Code CityAreaCode	(561)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	855-1626
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29934322257	shares
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	251221	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	499470	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2848916	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3110969	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1771106	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1457253	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	277178	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	242645	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	320404	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	215365	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	837460	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	837460	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	6306285	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6363162	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4320617	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4194299	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	259443	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	259443	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	9016072	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	9016072	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	164413	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	165530	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	505954	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	574256	usd
CY2023Q1	us-gaap	Assets Assets	20572784	usd
CY2022Q4	us-gaap	Assets Assets	20572762	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11755867	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11514322	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20014407	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19563808	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1348425	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1348425	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1780010	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	3003000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	2995000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	8322240	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	8622240	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	189875	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215063	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	455336	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	455336	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	48545733	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	49308157	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	316079	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359193	usd
CY2023Q1	us-gaap	Liabilities Liabilities	48861812	usd
CY2022Q4	us-gaap	Liabilities Liabilities	49667350	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29934322257	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29934322257	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29084322257	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29084322257	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2993432	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2908432	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1671486835	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1671571834	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1702772220	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1703577780	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-28289028	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-29094588	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20572784	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20572762	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4915896	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1144520	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1853046	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1374643	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2216670	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1572336	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94135	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	116824	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	4163851	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	3063803	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	752045	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1919283	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	42746	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	268806	usd
CY2023Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	563032	usd
CY2022Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	5282	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	552263	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	620937	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	53515	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-346849	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	805560	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2266132	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	805560	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2266132	usd
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-1434	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	805560	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2267566	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	135924745	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	805560	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-138192311	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-28.71
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-28.71
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29754877813	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4812754	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	509813067665	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4812754	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-29094588	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	805560	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-28289028	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-27301524	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-27301524	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2022Q1	RNVA	Stock Issued During Period Value Payment Of Cash In Lieu Of Fractional Shares StockIssuedDuringPeriodValuePaymentOfCashInLieuOfFractionalShares	9	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2267566	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2267566	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-28569099	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-28569099	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	805560	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2266132	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94135	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	116824	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	334819	usd
CY2023Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	563032	usd
CY2022Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	5282	usd
CY2022Q1	RNVA	Income Loss From Discontinued Operation Net Of Tax IncomeLossFromDiscontinuedOperationNetOfTax	1434	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-262053	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-140155	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	34533	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10764	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	105039	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22217	usd
CY2023Q1	RNVA	Increase Decrease In Security Deposit IncreaseDecreaseInSecurityDeposit	-1117	usd
CY2022Q1	RNVA	Increase Decrease In Security Deposit IncreaseDecreaseInSecurityDeposit	10000	usd
CY2023Q1	RNVA	Increase Decrease Right Of Use Asset IncreaseDecreaseRightOfUseAsset	-68302	usd
CY2022Q1	RNVA	Increase Decrease Right Of Use Asset IncreaseDecreaseRightOfUseAsset	-27412	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	241545	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	734227	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	439425	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	465651	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-68302	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-27412	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1141231	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1149357	usd
CY2022Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2323	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1141231	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1151680	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	220453	usd
CY2023Q1	RNVA	Receivable From Related Party ReceivableFromRelatedParty	313853	usd
CY2022Q1	RNVA	Receivable From Related Party ReceivableFromRelatedParty	127313	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-534306	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-127313	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-534306	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-127313	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	580000	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	750000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	572000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	300000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	563174	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	933418	usd
CY2022Q1	RNVA	Payments Of Accounts Receivable Sold Under Sales Agreements PaymentsOfAccountsReceivableSoldUnderSalesAgreements	-158824	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	1000000	usd
CY2022Q1	RNVA	Cash Paid For Fractional Shares In Connection With Reverse Stock Split CashPaidForFractionalSharesInConnectionWithReverseStockSplit	9	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-855174	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	657749	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-855174	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	657749	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-248249	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-621244	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	499470	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	724524	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	251221	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	103280	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zaprfhStnrR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zDBJD6puugb6">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of net revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include the estimates of fair values of assets acquired and liabilities assumed in business combinations, contractual allowances and bad debt reserves, the recoverability of long-lived assets, the valuation allowance relating to the Company’s deferred tax assets, the valuations of investments, equity and derivative instruments, deemed dividends, litigation and related reserves, among others. Actual results could differ from those estimates and would impact future results of operations and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z0kUIJHVkGAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zTnu7r2N36Zg">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023Q1	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	11100000	usd
CY2022Q1	RNVA	Estimated Contractual Allowance EstimatedContractualAllowance	8100000	usd
CY2023Q1	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	900000	usd
CY2022Q1	RNVA	Estimated Implicit Price Concession EstimatedImplicitPriceConcession	1400000	usd
CY2023Q1	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	12000000.0	usd
CY2022Q1	RNVA	Allowance For Adjustment Of Revenue AllowanceForAdjustmentOfRevenue	9500000	usd
CY2023Q1	us-gaap	Revenues Revenues	4900000	usd
CY2022Q1	us-gaap	Revenues Revenues	1100000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.052
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.052
CY2023Q1	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	0	usd
CY2022Q1	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	135700000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-138192311	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29754877813	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4812754	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	27733334296	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	452324855556	shares
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10,000
CY2022Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	10000	shares
CY2023Q1	RNVA	Working Capital Deficit WorkingCapitalDeficit	42200000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-28300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	800000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2300000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3300000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	805560	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2266132	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	135924745	usd
CY2023Q1	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	805560	usd
CY2022Q1	RNVA	Net Loss Available To Common Shareholders Continuing Operations NetLossAvailableToCommonShareholdersContinuingOperations	-138190877	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1434	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	805560	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	509813067665	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4812754	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.00
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-28.71
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-28.71
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	512377850152	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8485007886	shares
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	12873266	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	13046646	usd
CY2023Q1	RNVA	Allowance For Contractual Obligations AllowanceForContractualObligations	8874259	usd
CY2022Q4	RNVA	Allowance For Contractual Obligations AllowanceForContractualObligations	8529904	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1150091	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1405773	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2848916	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3110969	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8496774	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8533710	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	552099	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	552099	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	6176589	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	5736096	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	534550	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	534550	usd
CY2023Q1	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	1976423	usd
CY2022Q4	RNVA	Overpayment Reserve Current OverpaymentReserveCurrent	2101837	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2277972	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2105516	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20014407	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19563808	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3100000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	3000000.0	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	4000000.0	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	4000000.0	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1780010	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q1	RNVA	Debt Current Excluding Notes Payable DebtCurrentExcludingNotesPayable	8322240	usd
CY2022Q4	RNVA	Debt Current Excluding Notes Payable DebtCurrentExcludingNotesPayable	8622240	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	13105250	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	14534630	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	13105250	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	14534630	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	1780010	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2917390	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1780010	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2917390	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	505954	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	574256	usd
CY2023Q1	RNVA	Lease Assets LeaseAssets	505954	usd
CY2022Q4	RNVA	Lease Assets LeaseAssets	574256	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	189875	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	215063	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	316079	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359193	usd
CY2023Q1	RNVA	Lease Liabilities LeaseLiabilities	726415	usd
CY2022Q4	RNVA	Lease Liabilities LeaseLiabilities	794717	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y5M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M2D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.130	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.130	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.049	pure
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	92569	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	49182	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	92569	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	49182	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	82892	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	56208	usd
CY2023Q1	RNVA	Future Minimum Lease Payments Including Accrued Interest FutureMinimumLeasePaymentsIncludingAccruedInterest	200000	usd
CY2022Q4	RNVA	Future Minimum Lease Payments Including Accrued Interest FutureMinimumLeasePaymentsIncludingAccruedInterest	200000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	243270	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	224252	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	221088	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	130547	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	594905	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	224252	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	88951	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3791	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	505954	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	220461	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	189875	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	220461	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	316079	usd
CY2023Q1	RNVA	Percentage Of Market Price PercentageOfMarketPrice	0.85	pure
CY2023Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	usd
CY2022Q1	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	135700000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	RNVA	Preferred Stock Voting Percentage PreferredStockVotingPercentage	0.51	pure
CY2023Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.90	pure
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29900000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29100000000	shares
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	111768	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	762250	usd
CY2023Q1	RNVA	Conversion Of Preferred Stock Into Common Stock One ConversionOfPreferredStockIntoCommonStockOne	36000	usd
CY2022Q1	RNVA	Conversion Of Preferred Stock Into Common Stock One ConversionOfPreferredStockIntoCommonStockOne	593330	usd
CY2023Q1	RNVA	Conversion Of Preferred Stock Into Common Stock Two ConversionOfPreferredStockIntoCommonStockTwo	40500	usd
CY2022Q1	RNVA	Deemed Dividends From Exchanges Of Debt For Preferred Stock DeemedDividendsFromExchangesOfDebtForPreferredStock	222222	usd
CY2022Q1	RNVA	Deemed Dividends For Trigger Of Down Round Provisions DeemedDividendsForTriggerOfDownRoundProvisions	135702523	usd
CY2023Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	600000	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	1115066	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable Current DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent	1115066	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	341046	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities Current DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent	341046	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1456112	usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	1434	usd

Files In Submission

Name	View Source	Status
rnva-20230331_def.xml	Edgar Link	unprocessable
0001493152-23-017256-index-headers.html	Edgar Link	pending
0001493152-23-017256-index.html	Edgar Link	pending
0001493152-23-017256.txt	Edgar Link	pending
0001493152-23-017256-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rnva-20230331.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
rnva-20230331_cal.xml	Edgar Link	unprocessable
rnva-20230331_lab.xml	Edgar Link	unprocessable
rnva-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNVA
Rennova Health, Inc. Stock $rnva

2023 Q2 Form 10-Q Financial Statement

#000149315223017256 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNVA Rennova Health, Inc. Stock $rnva

2023 Q2 Form 10-Q Financial Statement

#000149315223017256 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNVA
Rennova Health, Inc. Stock $rnva